<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-210
Date of Submission: 2025-04-18

This report was submitted by a Other Healthcare Professional from Black Ltd Medical Center concerning patient ANON-PX-3317. The subject is a 37-year-old male with a significant medical history including type 2 diabetes, migraines, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole (Proton-pump inhibitor) administered via the Intravenous route at a dosage of 438mg, initiated on 2025-02-18 for Gastroesophageal reflux disease with the course ongoing; Amoxicillin administered via the Intramuscular route at a dosage of 372mg, initiated on 2025-02-18 for Bacterial infection with the course ongoing.

On approximately 2025-03-06, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Diarrhea. The Stevens-Johnson syndrome was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Diarrhea was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: West recognize along them identify medical. Imagine attention throughout price. Organization must job character sense toward.</data>
report_id: ADR-2025-210
report_date: '2025-04-18'
patient_details:
  patient_id: ANON-PX-3317
  gender: Male
  relevant_history:
  - type 2 diabetes
  - migraines
  - anxiety
  age_at_reaction: 37
suspected_drugs:
- drug_name: Omeprazole
  dosage: 438mg
  route_of_administration: Intravenous
  start_date: '2025-02-18'
  indication_for_use: Gastroesophageal reflux disease
  drug_class: Proton-pump inhibitor
- drug_name: Amoxicillin
  dosage: 372mg
  route_of_administration: Intramuscular
  start_date: '2025-02-18'
  indication_for_use: Bacterial infection
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-03-06'
  severity: Mild
  outcome: Unknown
  intervention_required: false
- symptom_name: Diarrhea
  onset_date: '2025-03-06'
  severity: Life-threatening
  outcome: Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 9
reporting_facility: Black Ltd Medical Center
reporter_type: Other Healthcare Professional
notes: West recognize along them identify medical. Imagine attention throughout price.
  Organization must job character sense toward.
